Miguel Santín
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Short-course Rifamycin-based Regimens for Latent Tuberculosis in Patients With End-stage Kidney Disease (NCT05021731) | Miguel Santín | 2024-04-20 |
Track Miguel Santín automatically
Every clearance here is in the API, with alerts when new ones post.